Linked Life Data

15976963

Source:http://linkedlifedata.com/resource/pubmed/id/15976963

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-6-24
pubmed:abstractText
The availability of a reliable marker of infarct-related artery (IRA) patency status may permit early identification of patients with patent IRA, for whom repeat thrombolysis or rescue percutaneous coronary intervention (PCI) may not be necessary. We found that the ratio of serum myoglobin levels obtained before and 60-min after initiation of thrombolytic therapy provides a useful indication of the IRA patency status. When the 60-min myoglobin ratio was >4.0, the probability of a patent IRA was 90%, suggesting that emergency coronary angiography to determine their IRA status may be unnecessary when this pattern of release of myoglobin is observed. The low specificity of this marker could be addressed by its combined use with other noninvasive tests such as ST-segment resolution and the persistence of chest pain at the time of angiography.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0929-5305
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-4
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Evaluation of coronary artery patency using cardiac markers.
pubmed:affiliation
Clinical Laboratories Division, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. mtanasijev@partners.org
pubmed:publicationType
Journal Article